title: Glucosamine administration during resuscitation improves organ function after trauma hemorrhage.
abstract: Stress-induced hyperglycemia is necessary for maximal rates of survival after severe hemorrhage; however, the responsible mechanisms are not clear. One consequence of hyperglycemia is an increase in hexosamine biosynthesis, which leads to increases in levels of O-linked attachment of N-acetyl-glucosamine (O-GlcNAc) on nuclear and cytoplasmic proteins. This modification has been shown to lead to improved survival of isolated cells after stress. In view of this, we hypothesized that glucosamine (GlcNH2), which more selectively increases the levels of O-GlcNAc administration after shock, will have salutary effects on organ function after trauma hemorrhage (TH). Fasted male rats that underwent midline laparotomy were bled to a mean arterial blood pressure of 40 mmHg for 90 min and then resuscitated with Ringer lactate (four times the shed blood volume). Administration of 2.5 mL of 150 mmol L GlcNH2 midway during resuscitation improved cardiac output 2-fold compared with controls that received 2.5 mL of 150 mmol L NaCl. GlcNH2 also improved perfusion of various organs systems, including kidney and brain, and attenuated the TH-induced increase in serum levels of IL-6 (902+/-224 vs. 585+/-103 pg mL) and TNF-alpha (540+/-81 vs. 345+/-110 pg mL) (values are mean+/-SD). GlcNH2 administration resulted in significant increase in protein-associated O-GlcNAc in the heart and brain after TH. Thus, GlcNH2 administered during resuscitation improves recovery from TH, as assessed by cardiac function, organ perfusion, and levels of circulating inflammatory cytokines. This protection correlates with enhanced levels of nucleocytoplasmic protein O-GlcNAcylation and suggests that increased O-GlcNAc could be the mechanism that links stress-induced hyperglycemia to improved outcomes.
authors.affiliation: Department of Surgery, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL 35294-0005, USA.
authors.forename: Shaolong
authors.initials: S
authors.lastname: Yang
authors.forename: Lu-Yun
authors.initials: LY
authors.lastname: Zou
authors.forename: Pam
authors.initials: P
authors.lastname: Bounelis
authors.forename: Irshad
authors.initials: I
authors.lastname: Chaudry
authors.forename: John C
authors.initials: JC
authors.lastname: Chatham
authors.forename: Richard B
authors.initials: RB
authors.lastname: Marchase
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D005944:Glucosamine / Q000008:administration & dosage*; D006470:Hemorrhage / Q000150:complications / Q000378:metabolism / Q000628:therapy*; D006943:Hyperglycemia / Q000209:etiology / Q000378:metabolism; D008297:Male; D009687:Nuclear Proteins / Q000378:metabolism; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D020127:Recovery of Function / Q000187:drug effects*; D012039:Regional Blood Flow / Q000187:drug effects; D012151:Resuscitation; D014947:Wounds and Injuries / Q000150:complications / Q000378:metabolism / Q000628:therapy*
chemical_list: D009687:Nuclear Proteins; D005944:Glucosamine